Labetalol Hydrochloride
Who holds supplier records for Labetalol Hydrochloride? 14 organisations hold a current record for Labetalol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Italy (5) and United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Labetalol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/labetalol-hydrochloride
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Labetalol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- FLAMMA SPAItalyCEP Company GMP cert on recordActive DMF 16314 · latest filing Dec 2002
- Neuland Laboratories LimitedIndiaCEPActive DMF 30564 · latest filing Jun 2016
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 11779 · latest filing Dec 1995
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 34073 · latest filing Aug 2019
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 37306 · latest filing Aug 2022
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 38064 · latest filing Mar 2023
- CAMBREX PROFARMACO MILANO SRLItaly Company GMP cert on recordActive DMF 12758 · latest filing Nov 1997
- COSMA SPAItaly Company GMP cert on recordActive DMF 14702 · latest filing Feb 2000
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 34099 · latest filing Jan 2020
- PHLOW CORPUnited StatesActive DMF 35233 · latest filing Nov 2021
- PROCOS SPAItaly Company GMP cert on recordActive DMF 10918 · latest filing Jun 1994
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 23710 · latest filing Apr 2010
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 31584 · latest filing Mar 2017
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 37856 · latest filing Dec 2022
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Labetalol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2016-222 - Rev 05 Labetalol Hydrochloride | Jul 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2022-315 - Rev 02 Labetalol Hydrochloride | Jul 2026 | — |
| OLON S.P.A. Rodano | IT | CEP 2004-289 - Rev 06 Labetalol Hydrochloride | Apr 2026 | Inspected Mar 2025 Italy |
| FLAMMA S.P.A. Chignolo d'Isola | IT | CEP 2010-226 - Rev 04 Labetalol Hydrochloride | Oct 2024 | Inspected Nov 2024 Italy |
| SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal | IN | R0-CEP 2021-241 - Rev 00 Labetalol Hydrochloride | Aug 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Labetalol Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- MYLAN LABORATORIES LTDInactive DMF 19366 · filed Apr 2006
- Spain · Inactive DMF 17319 · filed Apr 2004
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 10901 · filed May 1994
- Italy · Inactive DMF 9927 · filed Oct 1992
- SIBEFAT SPAInactive DMF 8495 · filed Mar 1990
- GLAXOCHEM LTDInactive DMF 5715 · filed Feb 1985
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Labetalol Hydrochloride is a non-selective beta blocker with alpha-1 adrenergic receptor blocking activity used mainly in the treatment of high blood pressure. It mitigates hypertension by decreasing heart rate and reducing vascular resistance.
Chemical identity
- IUPAC name
- 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride
- Canonical SMILES
- CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl
- InChIKey
- WQVZLXWQESQGIF-UHFFFAOYSA-N
- Synonyms
- Normodyne API, ah 5158a, ah-5158a, ah-5158a hydrochloride, ibidomide hydrochloride, labetalol hcl, normodyne, nsc-290312, sch 15719w, sch-15719w, sch-15719w hydrochloride, trandate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- beta-Adrenergic Blocker
- Mechanism of action
- Adrenergic beta-Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Labetalol Hydrochloride?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Labetalol Hydrochloride: FLAMMA SPA (Italy), Neuland Laboratories Limited (India), OLON SPA (Italy), SRINI PHARMACEUTICALS PRIVATE LIMITED (India), Viyash Scientific Ltd (India), ALIVUS LIFE SCIENCES LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy) and COSMA SPA (Italy), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Labetalol Hydrochloride Drug Master Files are active?
FLAMMA SPA (DMF 16314), Neuland Laboratories Limited (DMF 30564), OLON SPA (DMF 11779), SRINI PHARMACEUTICALS PRIVATE LIMITED (DMF 34073), Viyash Scientific Ltd (DMF 37306), ALIVUS LIFE SCIENCES LTD (DMF 38064), CAMBREX PROFARMACO MILANO SRL (DMF 12758) and COSMA SPA (DMF 14702) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Labetalol Hydrochloride records mean?
6 organisations have only inactive Type II DMFs for Labetalol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Labetalol Hydrochloride have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Labetalol Hydrochloride on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), OLON S.P.A. Rodano (IT), FLAMMA S.P.A. Chignolo d'Isola (IT) and SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Labetalol Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Labetalol Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.